Do-nothing Congress: Lawmakers pass more blame than bills

• Congress is on track to have its least productive year in recent history


• Boehner blames the Democratic Senate, White House, cites 148 House-passed bills


• Many targeted Obamacare, dealt with shutdown with no chance of passage


• Democrats blame House conservatives for impeding legislative progress

Tune in to “Crossfire” on CNN Thursday at 6:30pm ET. Sen. Jon Tester (D-MT) and Rep. Adam Kinzinger (R-IL) join hosts S.E. Cupp and Stephanie Cutter to debate who is to blame for the do-nothing Congress.

Washington (CNN) — Congress is on pace to have its least productive year in modern history, earning a “do-nothing” label and adding another unwanted statistic to a body already facing chronically low approval ratings.

Cue the blame game.

“To date, the House has passed nearly 150 bills this Congress that the United States Senate has failed to act on,” Republican Speaker John Boehner argued Wednesday. “The Senate (and) the President continue to stand in the way of the people’s priorities.”

Democrats are tossing responsibility right back in the GOP’s lap, arguing that hardline House conservatives are blocking legislative progress.

• Number of laws passed so far by the 113th Congress — 56: Sound substantial? Check out the breakdown.

• Bills limited to one piece of land or region — 10: These include the Denali Park Improvement Act, the Freedom to Fish Act and the Minuteman Missile National Historic Site Boundary Modification Act.

• Reauthorization of laws –5: The U.S. Parole Commission, a congressional award program and a handful of other regular pieces of business were reauthorized — not exactly heavy lifting.

• Keeping government running — 5: Congress repeatedly had to vote to fund government and keep the bureaucracy from hitting its self-imposed debt ceiling.

• Naming things — 4: Congress voted to name a bridge, a VA building, an air traffic control tower and a section of the IRS Code.

• What else did they do? Most of the others were focused and had limited impact. One dealt with how to handle organ transplants from HIV+ donors. Another delayed new pipeline safety standards.

• There were a few heavy lifts: The House and Senate agreed on reauthorizing the Violence Against Women Act, prepared for a possible pandemic flu and handled the nation’s helium reserve, pivotal in the medical world.)

• Stuck in idle: Immigration; jobs and the economy; energy reform/Keystone pipeline/climate change; future Medicare insolvency; future Social Security insolvency.

Meanwhile, America’s national legislature is growing increasingly dysfunctional.

No deal, but sides said to be closer on budget deal

So far, 56 bills have been signed into law in the first session of the 113th Congress. Assuming legislators don’t pick up the pace next year — and the smart money says they won’t as the midterms draw near — this will become the least productive Congress in at least the last 40 years, according to a CNN analysis of congressional records.

Is the fact that fewer bills have become law necessarily a bad thing? That depends on your point of view. But representatives and senators on both sides of the aisle readily acknowledge that some major issues have not been addressed.

GOP obstruction of Obamacare is closing hospitals

Congress hasn’t passed a budget, among other things. None of the 12 annual spending bills has made it to the President’s desk. We don’t have a new farm bill. Immigration reform is stalled. Tax and entitlement reform are dead in the water.

Adding insult to injury, in October the federal government had its first partial shutdown in nearly two decades.

The most important issue in Washington political circles, naturally, is who’s responsible.

Democrats point out that roughly one-third of the 148 bills passed by the GOP-controlled House so far this year were attempts to repeal, delay or defund Obamacare that had zero chance of passing the Senate or surviving a certain presidential veto.

Washington could still screw up your holidays

More than a dozen of those measures were also partisan, piecemeal spending bills passed during the government shutdown that had no chance of being signed into law.

Some of them had nothing to do with major issues at all, such as the bills renaming courthouses in Sherman, Texas, and Fergus Falls, Minnesota.

Senate Majority Leader Harry Reid has called the House GOP a bunch of “modern-day anarchists.” But Republicans argue that Democrats are standing in the way of priorities such as entitlement reform. Democrats are standing in the way of a major overhaul of the tax code, they insist.

While both the House and the Senate passed farm bills, Democrats are blocking much-needed changes to the country’s agriculture laws, Republicans say.

As is usually the case in Washington, your opinion of which party is to blame is probably determined by which party you belong to. Meanwhile, Democrats and Republicans are growing more ideologically distant by the day.

And that is a recipe for gridlock.

Opinion: Here’s something Congress could actually do

CNN.com Recently Published/Updated

Do-nothing Congress: Lawmakers pass more blame than bills

A do-nothing Congress isn"t healthy

• Former congressman John Porter says Congress has done little up to August recess


• Among the issues he says Congress hasn’t tackled is more funding for health research


• He says people support more spending, and most would pay more taxes for research


• Porter: Health research is an investment that will benefit our childen and grandchildren

Editor’s note: John Porter, who served for 21 years as a Republican congressman from Illinois, is chairman of Research!America, an alliance which represents academic, industry, patient groups and other organizations, to advocate for greater public investment in research for health. The alliance is primarily funded by member organizations including pharmaceutical companies and philanthropists. He is a partner in the law firm of Hogan & Lovells.

(CNN) — At every congressional recess, the question remains: What has Congress accomplished to advance medical innovation, or for that matter any of our national priorities?

A ritual of leaving town with no meaningful action on pressing issues seems to have taken hold as lawmakers once again meet with voters in their districts. Indeed, much will happen during this break, but as elected officials hold yet another town hall meeting, Facebook or Twitter chat or public event, thousands will be diagnosed with cancer or get the dreaded confirmation from a physician that they or a loved one has Alzheimer’s disease. Thousands will suffer a heart attack or stroke, and thousands of parents will learn that their child has a rare disease.

Researchers are racing against the clock to identify a new gene or molecule that could lead to the next medical breakthrough and bring us closer to cures and new therapies to halt disease.

Time is of the essence in the scientific community, but unfortunately, our elected leaders continue to squander precious time in political, ideological battles that yield little or no results. Is this the Congress you elected? This is not the first elected body to tackle formidable challenges, but it may be the first that has failed miserably in addressing critical issues that will have short- and long-term implications for the health and well-being of Americans.

Spending bills to fund the National Institutes of Health, the Centers for Disease Control and other agencies in the next fiscal year remain in limbo as sequestration, across-the-board spending cuts enacted in March, tightens its grip on medical innovation. As a result of these mindless budget cuts, researchers are delaying or scrubbing promising studies. Institutions across the country have closed labs, reduced their work forces and implemented hiring freezes. Young scientists are rethinking their career paths or moving abroad to countries that have accelerated investments in research.

Many commentators have noted that the 113th Congress is on track to be the least productive in recent history. Fewer than three dozen bills have been passed by this Congress and signed into law.

This new style of legislating, when there is any, seems to be brinksmanship at the last possible moment: Hail Mary passes to avert a government shutdown and the like. If the head of a Fortune 500 company performed in this manner, he would be given the boot. Perhaps voters should think the same of those obstructionists on Capitol Hill who block action on measures to advance science and innovation the next time they head to the polls. In the meantime, it’s important for all of us who care about the future of biomedical and health research to get engaged.

It’s a myth that members of Congress don’t pay attention in the month of August. On the contrary, during this recess, they are meeting with their constituents to at least shore up support for their next campaigns.

This is the time to tell them that voters are expecting action, not more heated rhetoric. It’s time to tell them that tax and entitlement reform is essential — rational proposals that will reduce health care costs and sustain investments in research and development. Research and development is now classified as an investment rather than an expense by the Bureau of Economic Analysis in calculating the gross domestic product, a sensible approach in recognizing the value of R&D in generating future income and bolstering our economy.

Now, if only our esteemed leaders in Washington will do likewise. They must abandon the notion that research isn’t highly valued by most Americans compared with bread-and-butter issues. In fact, more than half of Americans are willing to spend more in taxes if they were certain that all of the money would be spent on additional medical research, according to polling (PDF) commissioned by Research!America, a nonprofit advocacy alliance.

Americans understand the importance of a long-term investment in medical and health research to spur private-sector innovation and produce the therapies, medical devices and treatments that will save lives. The importance of long-term priorities is, by the way, one of the ways a nation stands apart from a corporation beholden to shareholder demands for immediate return.

A nation’s leadership must view research through the prism of future generations: our children and grandchildren, who will benefit from both a health and economic standpoint as a result of today’s scientific discoveries. Imagine a world free of cancer, free of AIDS, free of Alzheimer’s, free of heart disease. It’s certainly possible if elected officials get beyond the rhetoric and take decisive action to strengthen our nation’s investments in research.

Follow us on Twitter @CNNOpinion.

Join us on Facebook/CNNOpinion.

The opinions expressed in this commentary are solely those of John E. Porter.

CNN.com – Politics

A do-nothing Congress isn"t healthy